Trading at a discount across both intrinsic cash flow and relative peer multiples, indicating a strong margin of safety.
Moderate quality score of 71/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Solid fundamental quality, though solvency presents a headwind.
Wall Street sentiment is generally neutral. However, capital return yields remain modest, anchored by a strong, well-covered dividend yield.
IBN exhibits elite business quality, driven by exceptional capital efficiency and highly lucrative margins. This is backed by a fortress balance sheet, holding significant net cash ($346.5B) and minimal debt risk.
The company maintains stable top-line performance paired with highly explosive earnings growth (26.1% EPS 3Y CAGR). This growth is supported by elite operational efficiency, sustaining an impressive 25.0% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $745.8B | +25.2% | — | — | +12.6% | |
| EBITDA | $195.6B | — | +39.3% | — | — | |
| Net Income | $135.6B | +15.3% | +26.7% | — | +15.3% | |
| EPS (Diluted) | $37.42 | +14.6% | +26.1% | +37.4% | +14.1% | |
| Free Cash Flow | $0.00 | -49.6% | -0.1% | +4.0% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 68.1% | 68.6% | 65.7% | 59.5% |
| Operating Margin | 25.0% | 25.5% | 21.2% | 14.6% |
| Net Margin | 17.5% | 18.2% | 16.4% | 11.7% |
| FCF Margin | — | 40.5% | 51.1% | 41.5% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.39 | $0.41 | +5.1% | ||
| Q1'26 | $0.38 | $0.35 | -7.9% | ||
| Q4'25 | $0.37 | $0.39 | +5.4% | ||
| Q3'25 | — | $0.44 | — | ||
| Q3'25 | $0.40 | $0.43 | +7.5% | ||
| Q2'25 | $0.37 | $0.41 | +10.8% | ||
| Q1'25 | $0.35 | $0.39 | +11.4% | ||
| Q4'24 | $0.35 | $0.43 | +22.9% |
Total return is -13.8% (1Y), lagging the benchmark by -38.8%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -6.8% | -16.1% | — |
| 1Y | -13.8% | -38.8% | +0.8% |
| 3YCAGR | +8.2% | -11.4% | +3.0% |
| 5YCAGR | +11.3% | -1.6% | +5.1% |
| 10YCAGR | +16.1% | +2.4% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about ICICI Bank Limited (IBN) valuation, health, and returns.
ICICI Bank Limited is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Cheap versus peers compared to industry peers. undervalued (implying +43.1% upside to DCF intrinsic value of $39.98)
ICICI Bank Limited has multiple valuation anchors: DCF Intrinsic Value: $39.98 | Peer Relative Fair Value: $846.82. A convergence of these signals offers higher conviction.
ICICI Bank Limited displays good financial health with a composite quality score of 71/100, supported by a Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 10.9%.
ICICI Bank Limited pays a 0.8% dividend yield, covered by a 14% payout ratio with 4 years of growth, supplemented by a 0.0% buyback yield.
ICICI Bank Limited's current growth trajectory is Stable. The company achieved +25.2% 1Y revenue growth and +14.6% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Buy based on 6 analysts, beating EPS expectations in 92% of recent quarters with a 1-quarter streak. The consensus price target represents a N/A change from current levels.
Investment risks for ICICI Bank Limited include: -26.8% 1-year max drawdown. Volatility risk is characterized by a beta of 0.56x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.